Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04307576
Title A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Mats Heyman
Indications

T-cell acute lymphoblastic leukemia

B-cell acute lymphoblastic leukemia

Therapies

Imatinib

Blinatumomab

Inotuzumab ozogamicin

Age Groups: adult | child
Covered Countries DEU | BEL

Additional content available in CKB BOOST